In a population-based cohort study by Razaz et al ,1 risks of neurodevelopmental disorders in 2051 children of fathers taking ...

a Secure Care Program, Department of Psychiatry, Taunton State Hospital, Taunton, MA, USA, and Harvard Medical School, Boston, MA, USA, b Departments of Neurology ...

Functional neurological disorder (FND) is a common and disabling disorder that is often considered difficult to treat, particularly in adults. Psychological therapies are often recommended for FND.

3 Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK 4 Department of Psychology, and Behavioural and Clinical Neuroscience Institute, University of Cambridge, ...

2 Department of Forensic Pathology, Auckland Hospital, Auckland, New Zealand 3 Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand Correspondence to Professor A ...

2 Department of Neurology, IRYCIS, Hospital Ramon y Cajal, Madrid, Spain 3 Department of Neurology, Hospital Fundacion Alcorcon, Madrid, Spain 4 Department of Neurology, Hospital Puerta de Hierro, ...

Correspondence to Dr A J Larner, Cognitive Function Clinic, Walton Centre for Neurology and Neurosurgery, Lower Lane, Liverpool L9 7LJ, UK; a.larner{at}thewaltoncentre.nhs.uk While taking the history ...

6 Amyloidosis Research and Treatment Center, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy Correspondence to Professor Giampaolo Merlini, Amyloidosis Research and Treatment Centre, IRCCS ...

a Wolfson Brain Imaging Centre, MRC Cambridge Centre for Brain Repair and Academic Neurosurgical Unit, b Department of Anaesthesia and The Neurosciences Critical Care Unit, Addenbrooke’s Hospital, ...

Stroke Unit, Department of Neuroscience, University of Perugia, Perugia, Italy Correspondence to: Dr Maurizio Paciaroni Department of Neuroscience, University of Perugia, Via Enrico dal Pozzo, 06126 ...

Correspondence to: Professor P G E Kennedy Department of Neurology, University of Glasgow, Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, UK; p.g.kennedyclinmed.gla.ac ...

RG6102 is a bispecific 2+1 monoclonal antibody (mAb) under development for the treatment of Alz- heimer’s disease (AD). It combines the anti-amyloid beta antibody gantenerumab with a transferrin ...